Stockreport

Cue Biopharma Announces Closing of Initial Public Offering

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Cue Biopharma™, Inc., (NASDAQ: CUE) an immunotherapy company developing a novel, proprietary class of biologics en [Read more]